© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
This finding from a study of people switching from TDF to TAF for HIV treatment may also have implications for those on PrEP.
Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.
Research in human cells and mice found the antiretroviral suppressed harmful chronic inflammation linked to age-related disorders.
A new analysis finds that Gilead Sciences’ updated version of its key antiretroviral tenofovir may not actually offer any safety benefits.
The tablet contains the same combo as Symfi Lo (efavirenz/lamivudine/tenofovir disoproxil fumarate) but with a higher dose of efavirenz.
Symfi Lo contains efavirenz, lamivudine and tenofovir disoproxil fumarate (TDF); Cimduo contains TDF and lamivudine.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
